Nasdaq 100 pullbacks
Query: Nasdaq 100 stocks that have pulled back more than 10% from their 52-week high but still have positive EPS growth and forward P/E below 30 · data as of 2026-10-13
Screened the Nasdaq-100 for names >10% off their 52-week high that remain at/near their 150D SMA (longer-term trend intact), carry positive YoY EPS growth, and trade below 30x forward earnings. 12 stocks matched — ranked by smallest pullback first: ROST, REGN, GOOGL, VRTX, TXN, ASML, MU, GEHC, PYPL, WDAY, LRCX, STX, ADBE. Output is a single sortable table with filter fields shown explicitly, per-row qualitative comments, and a "How to Read This Screen" narrative splitting shallow-trend-continuation names from deep-value pullbacks.
As of October 13, 2026, 12 Nasdaq-100 constituents are trading at least 10% below their 52-week high yet remain at or near their 150-day moving average, keep positive YoY EPS growth, and trade below 30x forward earnings. The group skews toward mega-cap tech and biotech: Alphabet, ASML, Micron, Lam Research and Texas Instruments sit on the shallow end of the pullback (roughly 12-14% off highs) with intact uptrends, while Adobe, Seagate and Workday have corrected 24-34% yet still hold long-term trend support and single-digit-to-mid-teens forward multiples. Regeneron, Vertex and GE HealthCare represent the defensive health-care ballast, and PayPal bridges value and growth in financials.
Nasdaq-100 Pullbacks: >10% Off Highs, Still in Uptrend, Positive EPS Growth, Forward P/E < 30
| Symbol | Company | Sector | Industry | Market Cap | Price | % From 52W High | % From 150D SMA | % From 50D SMA | Forward P/E | P/E (TTM) | EPS Growth YoY | Revenue Growth YoY | 1M Return | 3M Return | 6M Return | 1Y Return | RSI (14) | Rel Volume | Momentum Potential | Volatility Potential | Technical Pattern | Days to Earnings | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROST | Ross Stores, Inc. | Consumer Discretionary | Apparel Retail | 7.239e+10 | 225.68 | -11.58% | -0.70% | -3.64% | 26.19 | 31.52 | 2.60% | 7.67% | -1.90% | 0.14% | 1.46% | 54.06% | 42.816 | 0.6914 | 66.3 | 43.1 | Downtrend | 37 | Off-price retail remains a share-gainer when trade-down behavior persists, but Ross is a tariff- and freight-cost story: imported apparel pricing is the key margin swing factor. Its pullback offers a lower-volatility defensive consumer entry versus the discretionary complex. |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | Biotechnology | 7.754e+10 | 753.12 | -11.61% | 4.06% | -4.59% | 12.43 | 18.63 | 2.09% | 0.99% | -5.12% | 13.47% | -1.66% | 29.79% | 45.4953 | 0.8565 | 83.8 | 34.6 | Uptrend | 17 | Trades at a deep discount to biotech peers despite a durable Eylea/Dupixent franchise — the market is pricing in Eylea biosimilar erosion. The catalyst is pipeline readouts and how well the higher-dose Eylea franchise defends share; balance sheet and free cash flow give it optionality for buybacks. |
| GOOGL | Alphabet Inc. | Communication Services | Internet Content & Information | 4.327e+12 | 353.78 | -12.13% | 1.92% | 2.34% | 23.95 | 17.75 | 32.01% | 15.09% | 1.26% | -4.56% | 6.40% | 49.93% | 58.1768 | 0.8304 | 75.6 | 22 | — | 16 | The only mega-cap trillion-dollar name on this list. The pullback is modest relative to its earnings power — cloud and search ad monetization plus aggressive AI capex make it the cleanest 'buy-quality-on-weakness' candidate. Watch whether AI infrastructure spend starts showing up in margins or becomes a capex overhang. |
| VRTX | Vertex Pharmaceuticals Incorpor | Health Care | Biotechnology | 1.23e+11 | 485.22 | -13.04% | 1.60% | -6.93% | 22.24 | 28.26 | 838.09% | 8.90% | -6.60% | 1.71% | 9.21% | 18.99% | 31.7802 | 1.0169 | 92.2 | 36.8 | Uptrend | 20 | A rare GARP setup among large biotech: cystic fibrosis is a near-monopoly with pricing power, and the non-CF pipeline (pain, kidney, type 1 diabetes) drives the next leg. Pulled back on pipeline-timing concerns rather than franchise erosion — a defensive health-care ballast here. |
| TXN | Texas Instruments Incorporated | Information Technology | Semiconductors | 2.629e+11 | 287.85 | -13.37% | 7.41% | 5.68% | 27.66 | 43.68 | 4.21% | 13.05% | 9.27% | -3.94% | 32.86% | 71.99% | 58.7915 | 0.8934 | 75.2 | 28.8 | Uptrend | 15 | Analogue/embedded cycle recovery is the thesis; the risk is that the automotive and industrial end-markets stay weak longer than expected. High capital return (dividends plus buybacks) supports the price on weakness, and the 300mm fab buildout is the margin lever to watch. Note the TTM multiple looks rich versus forward — earnings are expected to inflect. |
| ASML | ASML Holding N.V. - New York Re | Information Technology | Semiconductor Equipment & Materials | 7.437e+11 | 1,718 | -13.66% | 4.83% | -1.42% | 28.86 | 58.45 | 26.91% | 15.58% | 9.05% | -5.25% | 13.53% | 84.69% | 44.8015 | 1.1363 | 95.1 | 19.8 | Uptrend | 1 | The purest AI-lithography toll-booth. The pullback reflects geopolitical and China-export noise more than demand, with EUV backlog and High-NA ramp intact. Highest momentum potential in the group; a semiconductor-capex scare is the main risk. |
| MU | Micron Technology, Inc. | Information Technology | Semiconductors | 1.078e+12 | 953.19 | -21.46% | 16.54% | -2.93% | 6.16 | 21.56 | 997.56% | 48.85% | 3.16% | 5.41% | 104.73% | 425.40% | 40.3494 | 0.9309 | 98.4 | 29.3 | Uptrend | 71 | Memory upcycle is doing the heavy lifting — DRAM/HBM pricing has driven an extraordinary earnings inflection, so the low forward multiple reflects cyclical peak-earnings optics, not a cheap stock. The key risk is that HBM supply catches demand and pricing rolls over; the reward is continued AI-server memory tightness. |
| GEHC | GE HealthCare Technologies Inc. | Health Care | Medical Devices | 3.107e+10 | 68.79 | -21.97% | 2.63% | 0.21% | 12.71 | 15.85 | 5.07% | 4.84% | 7.07% | 8.91% | -7.82% | -2.94% | 60.6227 | 0.9026 | 39.3 | 24 | — | 15 | Medical-imaging franchise with a services and software attach tailwind; spinning out from GE has sharpened capital allocation. The pullback came alongside broad med-tech weakness (recent JNJ device-sales disappointment), but GEHC's imaging backlog and installed-base service revenue are steadier than the tape implies. |
| PYPL | PayPal Holdings, Inc. | Financials | Credit Services | 4.805e+10 | 56.17 | -23.08% | 12.56% | 0.05% | 9.7 | 10.62 | 26.19% | 4.32% | 3.96% | 1.42% | 17.77% | -18.68% | 58.6696 | 0.6556 | 72 | 22.1 | Uptrend | 14 | Cheapest forward multiple of the group and a genuine value-with-growth profile: branded-checkout and Braintree volumes plus cost discipline under new management. The debate is competitive pressure from Apple Pay and stablecoins eating wallet share — a re-rating depends on durable transaction-margin expansion. |
| WDAY | Workday, Inc. | Information Technology | Software - Application | 4.483e+10 | 186.02 | -24.28% | 23.11% | -2.18% | 14.72 | 58.13 | 31.75% | 13.09% | -4.22% | 31.17% | 57.83% | -20.22% | 47.4119 | 0.5768 | 67.5 | 64.4 | Uptrend | 49 | Subscription software that has been de-rated on seat-based AI disruption fears rather than fundamentals — ARR growth and margin expansion are intact. The deep pullback creates the deepest value-versus-growth gap in the software cohort, but note the elevated volatility score implies the market still prices real AI-disruption risk to its pricing model. |
| LRCX | Lam Research Corporation | Information Technology | Semiconductor Equipment & Materials | 3.768e+11 | 301.11 | -30.51% | 0.34% | -3.16% | 26.05 | 52.19 | 39.98% | 23.68% | 10.22% | -10.14% | 10.73% | 130.27% | 42.7893 | 0.8949 | 95.4 | 21.5 | Uptrend | 9 | WFE spending tied to AI-driven memory and advanced-logic capex. The recent sharp drawdown follows the sector's capex-fear selloff (peer AMAT has been hit harder), offering a cyclically-levered entry with strong momentum score. Earnings are imminent — a near-term catalyst as well as event risk. |
| STX | Seagate Technology Holdings PLC | Information Technology | Computer Hardware | 1.699e+11 | 747.2 | -31.70% | -2.66% | -12.20% | 13.49 | 53.68 | 338.51% | 38.86% | -7.17% | -9.72% | 40.28% | 250.59% | 36.8333 | 1.4734 | 89.1 | 75.5 | Uptrend | 15 | Nearline/HDD demand for AI data lakes has produced a spectacular earnings surge, pushing the TTM multiple well above the forward one. The stock is the most extended momentum name here with the highest volatility score — the deep pullback reflects profit-taking after a parabolic run, so position sizing matters more than the headline discount. |
| ADBE | Adobe Inc. | Information Technology | Software - Application | 9.196e+10 | 236.28 | -34.35% | -3.11% | -8.18% | 8.59 | 13.52 | 28.24% | 10.53% | -11.04% | 5.22% | 0.24% | -29.99% | 42.3355 | 0.7401 | 79.2 | 22.4 | — | 57 | The value case is compelling — a mid-single-digit forward multiple for a cash-generative software franchise — but this is a genuine 'AI disruption' discount, not just sentiment. Firefly monetization and enterprise AI tiers are the bull case; a slow seat-based erosion is the bear case. Long-term trend support is the line to watch. |
How to Read This Screen
How to read this screen
This is a quality-on-weakness list: Nasdaq-100 members that have given back 10% or more from their 52-week highs, yet have not broken their longer-term trend (price within 5% of the 150-day SMA and the 50/150-day structure still constructive), keep positive YoY EPS growth, and still trade below 30x forward earnings. Names with negative or missing EPS growth and those with forward multiples of 30x+ are excluded by construction.
Two distinct buckets emerge:
- Shallow pullbacks, strong trend — Alphabet, ASML, Micron, Lam Research and Texas Instruments are only ~12–15% off their highs with intact uptrends and high momentum scores. These are trend-continuation candidates where the dip is consolidation, not damage.
- Deep pullbacks, value multiples — Adobe, Seagate, Workday and PayPal have corrected 23–34% but now trade at single-digit-to-mid-teens forward multiples. Here the risk is more fundamental (AI disruption to seat-based software, cyclical memory/HDD earnings, fintech competition) than technical.
Health care (Regeneron, Vertex, GE HealthCare) provides the defensive counterweight — steady franchises trading at reasonable multiples after sector-wide de-rating rather than company-specific deterioration.
Watch-list items: several names report within the next two weeks, making near-term catalysts (e.g. Lam Research) also event risk. Where the trailing P/E materially exceeds the forward P/E, the market is underwriting an earnings inflection — validate the direction of that inflection before treating the forward multiple as cheap.
Missing Out
How to read this screen
This is a quality-on-weakness list: Nasdaq-100 members that have given back 10% or more from their 52-week highs, yet have not broken their longer-term trend (price within 5% of the 150-day SMA and the 50/150-day structure still constructive), keep positive YoY EPS growth, and still trade below 30x forward earnings. Names with negative or missing EPS growth and those with forward multiples of 30x+ are excluded by construction.
Two distinct buckets emerge:
- Shallow pullbacks, strong trend — Alphabet, ASML, Micron, Lam Research and Texas Instruments are only ~12–15% off their highs with intact uptrends and high momentum scores. These are trend-continuation candidates where the dip is consolidation, not damage.
- Deep pullbacks, value multiples — Adobe, Seagate, Workday and PayPal have corrected 23–34% but now trade at single-digit-to-mid-teens forward multiples. Here the risk is more fundamental (AI disruption to seat-based software, cyclical memory/HDD earnings, fintech competition) than technical.
Health care (Regeneron, Vertex, GE HealthCare) provides the defensive counterweight — steady franchises trading at reasonable multiples after sector-wide de-rating rather than company-specific deterioration.
Watch-list items: several names report within the next two weeks, making near-term catalysts (e.g. Lam Research) also event risk. Where the trailing P/E materially exceeds the forward P/E, the market is underwriting an earnings inflection — validate the direction of that inflection before treating the forward multiple as cheap.
Run a version of this yourself
Describe the idea in plain English and Relaxfolio returns a researchable shortlist with the charts, fundamentals, and risks attached.
Educational research tool — not investment advice. A screen is a starting point, not a recommendation.